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Background
In the previous studies, it has been shown that dopamin-
ergic mechanisms are related to the production and elab-
oration of acute and chronic stress. The ventral
hippocampus is one of the important brain sites involved
in modulation of fear and anxiety.
Materials and methods
To test the effects of dopaminergic system in the ventral
hippocampus (VH), we investigated the effect of apomor-
phine, sulpiride (D2 receptor antagonist) and SCH 23390
(D1 receptor antagonist) microinjections into the VH on
the behaviors displayed by male Wistar rats in the elevated
plus-maze. In these experiments, animals weighting
220?280 g at the time of surgery were used. Eight animals
were used in each group of experiments. After bilaterally
cannulating of the animals in the VH by stereotaxic instru-
ment, they were allowed to recover 1-week before behav-
ioral testing. All procedures were carried out in accordance
with institutional guidelines for animal care and use. Test
videotapes were scored for conventional indices of anxiety
(percent open arm entries / time) and locomotor activity
(closed arm entries).
Results
Bilateral intra-VH injections of the different doses of apo-
morphine (0.1, 0.5, 1 microgram per rat) increased the
percentage of open arm time (%OAT) and open arm
entries (%OAE). The results suggest that apomorphine
produces a significant anxiolytic effect without any
changes in the locomotor activity. Similarly, intra-VH
microinjections of sulpiride (0.2, 1, 5 micrograms per
rat), but not SCH 23390 (0.01, 0.1, 1 microgram per rat),
has increased (%OAE) indicating an anxiolytic action. The
observed effect of sulpiride may be mediated through
dopamine release from the dopaminergic terminals in the
VH.
Conclusions
In conclusion, dopaminergic system of the VH can elicit
anxiolytic behavior.
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